[Federal Register Volume 84, Number 23 (Monday, February 4, 2019)]
[Notices]
[Pages 1471-1472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00360]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Clinical Care Commission

AGENCY: Office of Disease Prevention and Health Promotion, Office of 
the Assistant Secretary for Health, Office of the Secretary, Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct a virtual meeting on February 20, 2019. The Commission is 
charged to evaluate and make recommendations to the U.S. Department of 
Health and Human Services (HHS) Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases.

DATES: The meeting will take place on February 20, 2019, from 1:00 p.m. 
to approximately 5:00 p.m. Eastern Time (ET).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://events.kauffmaninc.com/events/nccc2/register/?t=24.

FOR FURTHER INFORMATION CONTACT: Clydette Powell, Designated Federal 
Officer, National Clinical Care Commission, U.S. Department of Health 
and Human Services, Office of the Assistant Secretary for Health, 
Office of Disease Prevention and Health Promotion, 1101 Wootton 
Parkway, Suite LL-100, Rockville, MD 20852. Email: <a href="/cdn-cgi/l/email-protection#0a45425b4a626279246d657c"><span class="__cf_email__" data-cfemail="f9b6b1a8b991918ad79e968f">[email protected]</span></a>. Phone: 
240-453-8239. Additional information may be obtained at https://health.gov/hcq/national-clinical-care-commission.asp.

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals and entities who 
represent diverse disciplines and views. The Commission will evaluate 
and make recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to awareness and clinical care for complex metabolic or 
autoimmune diseases that result from issues related to insulin that 
represent a significant disease burden in the United States, which may 
include complications due to such diseases.
    The inaugural meeting of the Commission was held on October 31, 
2018, during which non-federal Commission members were sworn-in, and 
various federal interagency efforts surrounding diabetes program were 
presented. This virtual meeting will consist of presentations by the 
remaining federal agencies on the Commission which were not covered in 
the inaugural meeting. The final meeting agenda will be available prior 
to the meeting at https://health.gov/hcq/national-clinical-care-commission.asp.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be no 
opportunity for oral comments at this virtual meeting. Written comments 
are welcome

[[Page 1472]]

throughout the process of the Commission and may be emailed to 
<a href="/cdn-cgi/l/email-protection#f8b7b0a9b890908bd69f978e"><span class="__cf_email__" data-cfemail="e6a9aeb7a68e8e95c8818990">[email protected]</span></a>, or by mail to the following address: Public Commentary, 
National Clinical Care Commission, 1101 Wootton Parkway, Suite LL-100, 
Rockville, MD 20852. Written comments should not exceed three pages in 
length.
    To virtually attend the Commission meeting, individuals must pre-
register at the registration website at https://events.kauffmaninc.com/events/nccc2/register/?t=24. Individuals who need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should indicate the special accommodation when 
registering online or by notifying Jennifer Gillissen at 
<a href="/cdn-cgi/l/email-protection#81ebe4efefe8e7e4f3afe6e8edede8f2f2e4efc1eae0f4e7e7ece0efe8efe2afe2eeec"><span class="__cf_email__" data-cfemail="84eee1eaeaede2e1f6aae3ede8e8edf7f7e1eac4efe5f1e2e2e9e5eaedeae7aae7ebe9">[email protected]</span></a> by February 11.

    Authority: The National Clinical Care Commission is required 
under the National Clinical Care Commission Act (Pub. L. 115-80). 
The Commission is governed by provisions of the Federal Advisory 
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) 
which sets forth standards for the formation and use of federal 
advisory committees.

    Dated: January 24, 2019.
Donald Wright,
Deputy Assistant Secretary for Health.
[FR Doc. 2019-00360 Filed 2-1-19; 8:45 am]
 BILLING CODE 4150-32-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>